Page last updated: 2024-08-24

4,4,4-trifluoro-1-phenyl-1,3-butanedione and acetohydroxamic acid

4,4,4-trifluoro-1-phenyl-1,3-butanedione has been researched along with acetohydroxamic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albert, DH; Augeri, DJ; Betebenner, D; Craig, R; Davidsen, SK; Fesik, SW; Guo, Y; Hajduk, PJ; Meadows, RP; Michaelides, M; Nettesheim, DG; Shuker, SB; Xu, L1

Other Studies

1 other study(ies) available for 4,4,4-trifluoro-1-phenyl-1,3-butanedione and acetohydroxamic acid

ArticleYear
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.
    Journal of medicinal chemistry, 2002, Dec-19, Volume: 45, Issue:26

    Topics: Animals; Biological Availability; Catalytic Domain; Hydroxamic Acids; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Models, Molecular; Naphthalenes; Protease Inhibitors; Protein Binding; Rats; Structure-Activity Relationship

2002